tiprankstipranks

Jeffrey S. Hackman Insider Profile

4 Followers
Jeffrey S. Hackman, CEO, Director at Fennec Pharmaceuticals, holds 65.14K shares in Fennec Pharmaceuticals (Ticker: FENC), holds 47.60K shares in Comera Life Sciences Holdings (Ticker: CMRA).
tipranks
Jeffrey S. Hackman

Jeffrey S. Hackman
Fennec Pharmaceuticals (FENC)
CEO, Director

Ranked #76,647 out of 108,328 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-26.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$623K
100.00%
0.00%
A breakdown of Jeffrey S. Hackman's holdings

Insider Roles

Fennec Pharmaceuticals
(FENC)
CEO, Director
Comera Life Sciences Holdings
(CMRA)
Chairman, President, and Chief Executive Officer., Director
Roles that Jeffrey S. Hackman holds in companies

Most Profitable Insider Trade

Stock:
Fennec Pharmaceuticals
(FENC)
Rating:Informative Buy
Date:May 19, 2025 - May 19, 2026
Return:+27.50%
The most profitable trade made by Jeffrey S. Hackman

Jeffrey S. Hackman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fennec Pharmaceuticals
Aug 03, 2026
CEO, Director
Uninformative Buy
$623.42K
Comera Life Sciences Holdings
Sep 12, 2022
Chairman, President, and Chief Executive Officer., Director
Informative Buy
98.06K
List of latest transactions for each holding click on a transaction to see Jeffrey S. Hackman's performance on stock

Jeffrey S. Hackman insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey S. Hackman?
The percentage of profitable transactions made by Jeffrey S. Hackman is 50%.
    What is the average return per transaction made by Jeffrey S. Hackman?
    The average return per transaction made by Jeffrey S. Hackman is -26.50%.
      What stocks does Jeffrey S. Hackman hold?
      Jeffrey S. Hackman holds: FENC, CMRA stocks.
        What was Jeffrey S. Hackman’s latest transaction?
        Jeffrey S. Hackman latest transaction was an Uninformative Buy of ―.
          What was Jeffrey S. Hackman's most profitable transaction?
          Jeffrey S. Hackman’s most profitable transaction was an Informative Buy of FENC stock on May 19, 2025. The return on the trade was 27.50%.
            What is Jeffrey S. Hackman's role in Fennec Pharmaceuticals?
            Jeffrey S. Hackman's role in Fennec Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.